GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis

Elizabeth Ann Coleman; Jeannette Y Lee; Stephen W Erickson; Julia A Goodwin; Naveen Sanathkumar; Vinay R Raj; Daohong Zhou; Kent D McKelvey; Senu Apewokin; Owen Stephens; Carol A Enderlin; Annette Juul Vangsted; Patty J Reed; Elias J Anaissie

doi:10.1007/s00520-014-2406-x

GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis

Elizabeth Ann Coleman, Jeannette Y Lee, Stephen W Erickson, Julia A Goodwin, Naveen Sanathkumar, Vinay R Raj, Daohong Zhou, Kent D McKelvey, Senu Apewokin, Owen Stephens, Carol A Enderlin, Annette Juul Vangsted, Patty J Reed, Elias J Anaissie

18 Citations (Scopus)

Abstract

PURPOSE: High-dose chemotherapy and autologous stem cell transplant (ASCT) to treat multiple myeloma (MM) and other cancers carries the risk of oral mucositis (OM) with sequelae including impaired nutritional and fluid intake, pain, and infectious complications. As a result of these problems, cancer treatment may have to be interrupted or delayed. In this study, we looked beyond OM's known risk factors of renal function and melphalan dose with a genome-wide association study (GWAS) to evaluate whether genetic variants in conjunction with clinical risk factors influence predisposition for OM.

METHODS: Genotyping was performed using Illumina HumanOmni1-Quad v1.0 BeadChip and further assessed for data quality. We tested 892,589 germline single-nucleotide polymorphisms (SNPs) for association with OM among 972 Caucasian patients treated with high-dose melphalan and ASCT in Total Therapy clinical trials (TT2, TT3, TT4) for newly diagnosed MM. Statistical analyses included t tests, stepwise regression modeling, and logistic regression modeling to find baseline clinical factors and genotypes associated with OM.

RESULTS: We found that 353 (36.3 %) patients had grades 2-4 OM. Type of treatment protocol, baseline estimated glomerular filtration rate, and melphalan dose along with baseline serum albumin and female gender predicted 43.6 % of grades 2-4 OM cases. Eleven SNPs located in or near matrix metalloproteinase 13, JPH3, DHRS7C, CEP192, CPEB1/LINC00692, FBN2, ALDH1A1, and DMRTA1/FLJ35282 were associated with grades 2-4 OM. The addition of these SNPs increased sensitivity in detecting grades 2-4 OM cases to 52 %.

CONCLUSIONS: These SNPs may be important for their roles in inflammatory pathways, epithelial healing, and chemotherapy detoxification.

Original language	English
Journal	Supportive Care in Cancer
Volume	23
Issue number	3
Pages (from-to)	841-9
Number of pages	9
ISSN	0941-4355
DOIs	https://doi.org/10.1007/s00520-014-2406-x
Publication status	Published - Mar 2015
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00520-014-2406-x

Cite this

Coleman, E. A., Lee, J. Y., Erickson, S. W., Goodwin, J. A., Sanathkumar, N., Raj, V. R., Zhou, D., McKelvey, K. D., Apewokin, S., Stephens, O., Enderlin, C. A., Vangsted, A. J., Reed, P. J., & Anaissie, E. J. (2015). GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis. Supportive Care in Cancer, 23(3), 841-9. https://doi.org/10.1007/s00520-014-2406-x

GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis. / Coleman, Elizabeth Ann; Lee, Jeannette Y; Erickson, Stephen W et al.
In: Supportive Care in Cancer, Vol. 23, No. 3, 03.2015, p. 841-9.

Research output: Contribution to journal › Journal article › Research › peer-review

Coleman, EA, Lee, JY, Erickson, SW, Goodwin, JA, Sanathkumar, N, Raj, VR, Zhou, D, McKelvey, KD, Apewokin, S, Stephens, O, Enderlin, CA, Vangsted, AJ, Reed, PJ & Anaissie, EJ 2015, 'GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis', Supportive Care in Cancer, vol. 23, no. 3, pp. 841-9. https://doi.org/10.1007/s00520-014-2406-x

@article{a5076a0d65274f2790fdc105edd7f656,

title = "GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis",

abstract = "PURPOSE: High-dose chemotherapy and autologous stem cell transplant (ASCT) to treat multiple myeloma (MM) and other cancers carries the risk of oral mucositis (OM) with sequelae including impaired nutritional and fluid intake, pain, and infectious complications. As a result of these problems, cancer treatment may have to be interrupted or delayed. In this study, we looked beyond OM's known risk factors of renal function and melphalan dose with a genome-wide association study (GWAS) to evaluate whether genetic variants in conjunction with clinical risk factors influence predisposition for OM.METHODS: Genotyping was performed using Illumina HumanOmni1-Quad v1.0 BeadChip and further assessed for data quality. We tested 892,589 germline single-nucleotide polymorphisms (SNPs) for association with OM among 972 Caucasian patients treated with high-dose melphalan and ASCT in Total Therapy clinical trials (TT2, TT3, TT4) for newly diagnosed MM. Statistical analyses included t tests, stepwise regression modeling, and logistic regression modeling to find baseline clinical factors and genotypes associated with OM.RESULTS: We found that 353 (36.3 %) patients had grades 2-4 OM. Type of treatment protocol, baseline estimated glomerular filtration rate, and melphalan dose along with baseline serum albumin and female gender predicted 43.6 % of grades 2-4 OM cases. Eleven SNPs located in or near matrix metalloproteinase 13, JPH3, DHRS7C, CEP192, CPEB1/LINC00692, FBN2, ALDH1A1, and DMRTA1/FLJ35282 were associated with grades 2-4 OM. The addition of these SNPs increased sensitivity in detecting grades 2-4 OM cases to 52 %.CONCLUSIONS: These SNPs may be important for their roles in inflammatory pathways, epithelial healing, and chemotherapy detoxification.",

author = "Coleman, {Elizabeth Ann} and Lee, {Jeannette Y} and Erickson, {Stephen W} and Goodwin, {Julia A} and Naveen Sanathkumar and Raj, {Vinay R} and Daohong Zhou and McKelvey, {Kent D} and Senu Apewokin and Owen Stephens and Enderlin, {Carol A} and Vangsted, {Annette Juul} and Reed, {Patty J} and Anaissie, {Elias J}",

year = "2015",

month = mar,

doi = "10.1007/s00520-014-2406-x",

language = "English",

volume = "23",

pages = "841--9",

journal = "Supportive Care in Cancer",

issn = "0941-4355",

publisher = "Springer",

number = "3",

}

TY - JOUR

T1 - GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis

AU - Coleman, Elizabeth Ann

AU - Lee, Jeannette Y

AU - Erickson, Stephen W

AU - Goodwin, Julia A

AU - Sanathkumar, Naveen

AU - Raj, Vinay R

AU - Zhou, Daohong

AU - McKelvey, Kent D

AU - Apewokin, Senu

AU - Stephens, Owen

AU - Enderlin, Carol A

AU - Vangsted, Annette Juul

AU - Reed, Patty J

AU - Anaissie, Elias J

PY - 2015/3

Y1 - 2015/3

N2 - PURPOSE: High-dose chemotherapy and autologous stem cell transplant (ASCT) to treat multiple myeloma (MM) and other cancers carries the risk of oral mucositis (OM) with sequelae including impaired nutritional and fluid intake, pain, and infectious complications. As a result of these problems, cancer treatment may have to be interrupted or delayed. In this study, we looked beyond OM's known risk factors of renal function and melphalan dose with a genome-wide association study (GWAS) to evaluate whether genetic variants in conjunction with clinical risk factors influence predisposition for OM.METHODS: Genotyping was performed using Illumina HumanOmni1-Quad v1.0 BeadChip and further assessed for data quality. We tested 892,589 germline single-nucleotide polymorphisms (SNPs) for association with OM among 972 Caucasian patients treated with high-dose melphalan and ASCT in Total Therapy clinical trials (TT2, TT3, TT4) for newly diagnosed MM. Statistical analyses included t tests, stepwise regression modeling, and logistic regression modeling to find baseline clinical factors and genotypes associated with OM.RESULTS: We found that 353 (36.3 %) patients had grades 2-4 OM. Type of treatment protocol, baseline estimated glomerular filtration rate, and melphalan dose along with baseline serum albumin and female gender predicted 43.6 % of grades 2-4 OM cases. Eleven SNPs located in or near matrix metalloproteinase 13, JPH3, DHRS7C, CEP192, CPEB1/LINC00692, FBN2, ALDH1A1, and DMRTA1/FLJ35282 were associated with grades 2-4 OM. The addition of these SNPs increased sensitivity in detecting grades 2-4 OM cases to 52 %.CONCLUSIONS: These SNPs may be important for their roles in inflammatory pathways, epithelial healing, and chemotherapy detoxification.

AB - PURPOSE: High-dose chemotherapy and autologous stem cell transplant (ASCT) to treat multiple myeloma (MM) and other cancers carries the risk of oral mucositis (OM) with sequelae including impaired nutritional and fluid intake, pain, and infectious complications. As a result of these problems, cancer treatment may have to be interrupted or delayed. In this study, we looked beyond OM's known risk factors of renal function and melphalan dose with a genome-wide association study (GWAS) to evaluate whether genetic variants in conjunction with clinical risk factors influence predisposition for OM.METHODS: Genotyping was performed using Illumina HumanOmni1-Quad v1.0 BeadChip and further assessed for data quality. We tested 892,589 germline single-nucleotide polymorphisms (SNPs) for association with OM among 972 Caucasian patients treated with high-dose melphalan and ASCT in Total Therapy clinical trials (TT2, TT3, TT4) for newly diagnosed MM. Statistical analyses included t tests, stepwise regression modeling, and logistic regression modeling to find baseline clinical factors and genotypes associated with OM.RESULTS: We found that 353 (36.3 %) patients had grades 2-4 OM. Type of treatment protocol, baseline estimated glomerular filtration rate, and melphalan dose along with baseline serum albumin and female gender predicted 43.6 % of grades 2-4 OM cases. Eleven SNPs located in or near matrix metalloproteinase 13, JPH3, DHRS7C, CEP192, CPEB1/LINC00692, FBN2, ALDH1A1, and DMRTA1/FLJ35282 were associated with grades 2-4 OM. The addition of these SNPs increased sensitivity in detecting grades 2-4 OM cases to 52 %.CONCLUSIONS: These SNPs may be important for their roles in inflammatory pathways, epithelial healing, and chemotherapy detoxification.

U2 - 10.1007/s00520-014-2406-x

DO - 10.1007/s00520-014-2406-x

M3 - Journal article

C2 - 25218607

SN - 0941-4355

VL - 23

SP - 841

EP - 849

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

IS - 3

ER -

GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this